BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20860824)

  • 21. hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines.
    Masi A; Becchetti A; Restano-Cassulini R; Polvani S; Hofmann G; Buccoliero AM; Paglierani M; Pollo B; Taddei GL; Gallina P; Di Lorenzo N; Franceschetti S; Wanke E; Arcangeli A
    Br J Cancer; 2005 Oct; 93(7):781-92. PubMed ID: 16175187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
    Amer R; Tiosano L; Pe'er J
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical features, treatment and prognosis of retinoblastoma in distant metastasis stage].
    Hu HM; Zhang WL; Wang YZ; Shi JT; Li B; Zhang Y; Li J; Wen Y; Huang DS
    Zhonghua Yan Ke Za Zhi; 2017 Feb; 53(2):121-127. PubMed ID: 28260363
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of retinoblastoma in Sub-Saharan Africa: Experience of the paediatric oncology unit at Gabriel Toure Teaching Hospital and the Institute of African Tropical Ophthalmology, Bamako, Mali.
    Traoré F; Sylla F; Togo B; Kamaté B; Diabaté K; Diakité AA; Diall H; Dicko F; Sylla M; Bey P; Desjardins L; Gagnepain-Lacheteau A; Coze C; Harif M; Doz F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27101. PubMed ID: 29697190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil.
    Antoneli CB; Ribeiro KC; Steinhorst F; Novaes PE; Chojniak MM; Malogolowkin M
    J Pediatr Hematol Oncol; 2006 Jun; 28(6):342-5. PubMed ID: 16794500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
    Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
    Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy and prognostic factors of chemoreduction combined with topical treatment for advanced intraocular retinoblastoma.
    Liu Y; Zhang X; Liu F; Wang KL
    Asian Pac J Cancer Prev; 2014; 15(18):7805-9. PubMed ID: 25292067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
    Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
    Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circular RNA (circ-0075804) promotes the proliferation of retinoblastoma via combining heterogeneous nuclear ribonucleoprotein K (HNRNPK) to improve the stability of E2F transcription factor 3 E2F3.
    Zhao W; Wang S; Qin T; Wang W
    J Cell Biochem; 2020 Jul; 121(7):3516-3525. PubMed ID: 32065448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H; Eagle RC; Shields CL; Shields JA
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoreduction for intraocular retinoblastoma in Malaysia.
    Menon BS; Juraida E; Alagaratnam J; Mohammad M; Ibrahim H; George TM; Ariffin H; Ho C; Khuzaiah R; Peng LH
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):2-4. PubMed ID: 17230058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
    Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
    Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray analysis and biochemical correlations of oxidative stress responsive genes in retinoblastoma.
    Vandhana S; Lakshmi TS; Indra D; Deepa PR; Krishnakumar S
    Curr Eye Res; 2012 Sep; 37(9):830-41. PubMed ID: 22668346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered calcium regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1 retinoblastoma cells.
    Mergler S; Cheng Y; Skosyrski S; Garreis F; Pietrzak P; Kociok N; Dwarakanath A; Reinach PS; Kakkassery V
    Exp Eye Res; 2012 Jan; 94(1):157-73. PubMed ID: 22182671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
    Wang XL; Niu YJ; Ma JM
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experimental research on in vivo gene-therapy of retinoblastoma].
    Chen D; Zhang X; Luo C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Aug; 16(4):211-5. PubMed ID: 10431044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.